Jacobs & Co. CA trimmed its stake in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 2.5% in the 4th quarter, HoldingsChannel reports. The firm owned 45,416 shares of the company’s stock after selling 1,169 shares during the period. Jacobs & Co. CA’s holdings in Procter & Gamble were worth $6,655,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Dfpg Investments LLC boosted its position in shares of Procter & Gamble by 1.7% in the 4th quarter. Dfpg Investments LLC now owns 24,892 shares of the company’s stock valued at $3,680,000 after purchasing an additional 424 shares during the period. Garrett Wealth Advisory Group LLC boosted its position in shares of Procter & Gamble by 6.3% in the 3rd quarter. Garrett Wealth Advisory Group LLC now owns 4,419 shares of the company’s stock valued at $645,000 after purchasing an additional 260 shares during the period. N.E.W. Advisory Services LLC boosted its position in shares of Procter & Gamble by 14.6% in the 3rd quarter. N.E.W. Advisory Services LLC now owns 94,424 shares of the company’s stock valued at $13,772,000 after purchasing an additional 12,016 shares during the period. Charles Schwab Investment Management Inc. boosted its position in shares of Procter & Gamble by 0.8% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 16,003,260 shares of the company’s stock valued at $2,298,184,000 after purchasing an additional 131,339 shares during the period. Finally, Royal Bank of Canada boosted its position in shares of Procter & Gamble by 26.9% in the 2nd quarter. Royal Bank of Canada now owns 10,823,380 shares of the company’s stock valued at $1,642,339,000 after purchasing an additional 2,293,824 shares during the period. 65.77% of the stock is owned by institutional investors and hedge funds.
Procter & Gamble Price Performance
PG stock opened at $162.61 on Thursday. The Procter & Gamble Company has a 52-week low of $141.45 and a 52-week high of $162.74. The stock’s fifty day simple moving average is $158.17 and its 200-day simple moving average is $152.09. The company has a quick ratio of 0.44, a current ratio of 0.64 and a debt-to-equity ratio of 0.48. The stock has a market capitalization of $382.62 billion, a price-to-earnings ratio of 27.24, a price-to-earnings-growth ratio of 3.28 and a beta of 0.44.
Procter & Gamble Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Thursday, February 15th. Investors of record on Friday, January 19th were given a $0.9407 dividend. This represents a $3.76 annualized dividend and a dividend yield of 2.31%. The ex-dividend date of this dividend was Thursday, January 18th. Procter & Gamble’s dividend payout ratio (DPR) is currently 62.98%.
Insider Buying and Selling
In related news, CEO Ma. Fatima Francisco sold 74,443 shares of the stock in a transaction on Wednesday, January 24th. The stock was sold at an average price of $153.30, for a total value of $11,412,111.90. Following the transaction, the chief executive officer now directly owns 973 shares of the company’s stock, valued at approximately $149,160.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other Procter & Gamble news, CEO R. Alexandra Keith sold 776 shares of the firm’s stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $158.11, for a total value of $122,693.36. Following the transaction, the chief executive officer now directly owns 4,859 shares of the company’s stock, valued at $768,256.49. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Ma. Fatima Francisco sold 74,443 shares of the firm’s stock in a transaction dated Wednesday, January 24th. The shares were sold at an average price of $153.30, for a total value of $11,412,111.90. Following the completion of the transaction, the chief executive officer now directly owns 973 shares in the company, valued at $149,160.90. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 279,063 shares of company stock valued at $43,187,745. 0.17% of the stock is currently owned by company insiders.
Wall Street Analyst Weigh In
Several analysts have commented on PG shares. Truist Financial raised Procter & Gamble from a “hold” rating to a “buy” rating and upped their price objective for the company from $160.00 to $175.00 in a research note on Monday, March 11th. The Goldman Sachs Group assumed coverage on Procter & Gamble in a research note on Friday, March 1st. They set a “neutral” rating and a $168.00 target price for the company. UBS Group increased their target price on Procter & Gamble from $172.00 to $178.00 and gave the stock a “buy” rating in a research note on Wednesday, January 24th. Stifel Nicolaus increased their target price on Procter & Gamble from $155.00 to $157.00 and gave the stock a “hold” rating in a research note on Wednesday, January 24th. Finally, JPMorgan Chase & Co. lowered their price target on Procter & Gamble from $169.00 to $162.00 and set an “overweight” rating on the stock in a report on Thursday, January 18th. Seven investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $168.41.
View Our Latest Stock Analysis on PG
Procter & Gamble Profile
The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.
Featured Articles
- Five stocks we like better than Procter & Gamble
- Short Selling: How to Short a Stock
- Bitcoin Depot Falls Into Value Territory With Expansion Underway
- Are Penny Stocks a Good Fit for Your Portfolio?
- 7 Stocks That Will Drive the Weight Loss Drugs Market
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Cintas or UniFirst: Investors Win Either Way
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.